Erythropoiesis-stimulating agents: benefits and risks in supportive care of cancer.

Curr Oncol · 2008 · PMC2216424 · PMID 18231643

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Results from the Medical Outcomes Study Short Form–36 ( sf –36) showed a trend in the same direction, but did not reach significance ( Table III ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.